The Global Burden of Disease (GBD) 2021 analysis showed a higher prevalence of schizophrenia in males.1
- Male ASPR: 291.6 per 100,000 (95% UI: 241.6, 345.0)
- Female ASPR: 263.6 per 100,000 (95% UI: 217.7, 311.9)
A similar pattern is observed with incidence.1 Various GBD analyses show mostly similar sex patterns across countries and SDI regions.2-4 The male-to-female prevalence ratio has remained stable over the past three decades, with a consistently higher global risk of schizophrenia observed in males.2,5
ASIR=age-standardized incidence rate; SDI=sociodemographic index; UI=uncertainty interval.
Related content
Continuous maintenance therapy is associated with a lower risk of relapse than intermittent treatment, supporting ongoing treatment strategies in schizophrenia and related psychotic disorders.
Treatment response tends to be higher during a first episode than during subsequent episodes, emphasizing the importance of early intervention and effective management.
Negative symptoms are a core feature of schizophrenia and can have a profound impact on functioning, social relationships, and quality of life.